Cancer HealthCast: This AI Tool Could Predict a Patient's Response to Immunotherapy

Artificial Intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology. Dr. Eytan Ruppin, chief of NCI's Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB). Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.